Notably, 72% of participants with prediabetes at baseline reverted to normoglycemia during Retatrutide treatment, indicating potential for diabetes prevention in at-risk populations
In mid to late 2025, around 12.4% of US adults reported taking a GLP-1 medicine specifically for weight loss, up from 5.8% in February 2024, according to Gallup survey data of more than 15,000 adults
Your PlexusDx clinician will review all current medications during your consultation
Chronic fatigue syndrome also known as myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) OR systemic exertional intolerance disease (SEID) is a serious, chronic illness that can cause pain and extreme fatigue
The survey included the HM-PRO, demographics, and personal experiences
Some patients may find that their energy levels stabilize over time as their bodies adjust to the medication, while others may need to explore additional strategies, such as dietary adjustments or exercise, to combat fatigue effectively